Reversible Infertility Associated with Testosterone Therapy for Symptomatic Hypogonadism in Infertile Couple
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: Androgen replacement therapy has been shown to be safe and effective for most patients with testosterone deficiency. Male partners of infertile couples often report significantly poorer sexual activity and complain androgen deficiency symptoms. We report herein an adverse effect on fertility caused by misusage of androgen replacement therapy in infertile men with hypogonadal symptoms. Materials and Methods: The study population consisted of 8 male patients referred from a local clinic for azoospermia or severe oligozoospermia between January 2008 and July 2011. After detailed evaluation at our andrology clinic, all patients were diagnosed with iatrogenic hypogonadism associated with external androgen replacement. We evaluated changes in semen parameters and serum hormone level,and fertility status. Results: All patients had received multiple testosterone undecanoate (NebidoR) injections at local clinic due to androgen deficiency symptoms combined with lower serum testosterone level. The median duration of androgen replacement therapy prior to the development of azoospermia was 8 months (range: 4-12 months). After withdrawal of androgen therapy, sperm concentration and serum follicle-stimulating hormone level returned to normal range at a median 8.5 months (range: 7-10 months). Conclusion: Misusage of external androgen replacement therapy in infertile men with poor sexual function can cause temporary spermatogenic dysfunction, thus aggravating infertility.
Abstract
Purpose: Androgen replacement therapy has been shown to be safe and effective for most patients with testosterone deficiency. Male partners of infertile couples often report significantly poorer sexual activity and complain androgen deficiency symptoms. We report herein an adverse effect on fertility caused by misusage of androgen replacement therapy in infertile men with hypogonadal symptoms. Materials and Methods: The study population consisted of 8 male patients referred from a local clinic for azoospermia or severe oligozoospermia between January 2008 and July 2011. After detailed evaluation at our andrology clinic, all patients were diagnosed with iatrogenic hypogonadism associated with external androgen replacement. We evaluated changes in semen parameters and serum hormone level,and fertility status. Results: All patients had received multiple testosterone undecanoate (NebidoR) injections at local clinic due to androgen deficiency symptoms combined with lower serum testosterone level. The median duration of androgen replacement therapy prior to the development of azoospermia was 8 months (range: 4-12 months). After withdrawal of androgen therapy, sperm concentration and serum follicle-stimulating hormone level returned to normal range at a median 8.5 months (range: 7-10 months). Conclusion: Misusage of external androgen replacement therapy in infertile men with poor sexual function can cause temporary spermatogenic dysfunction, thus aggravating infertility.
참고문헌 (16)
- Steptoe PC, "Birth after the reimplantation of a human embryo", Lancet, 2, pp.366~ (1978)
- Palermo G, "Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte", Lancet, 340, pp.17~18 (1992)
- O’Brien JH, "Erectile dysfunction and andropause symptoms in infertile men", J Urol, 174, pp.1932~1934 (2005)
- Monga M, "Impact of infertility on quality of life, marital adjustment, and sexual function", Urology, 63, pp.126~130 (2004)
- Shabsigh R, "Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone", J Urol, 172, pp.658~663 (2004)
- Harle L, "Nebido: a long-acting injectable testosterone for the treatment of male hypogonadism", Expert Opin Pharmacother, 6, pp.1751~1759 (2005)
- World Health Organization, "WHO Laboratory manual for the examination of human semen and sperm-cervical mucus interaction" (1999), Cambridge University Press
- Jan Z, "Reversible testosterone-induced azoospermia in a 45-year-old man attending an infertility outpatient clinic", Andrologia, 44(1), pp.823~825 (2012)
- Lenzi A, "Stress, sexual dysfunctions, and male infertility", J Endocrinol Invest, 26(3), pp.72~76 (2003)
- Seidman SN, "The relationship between depression and erectile dysfunction", Curr Psychiatry Rep, 2, pp.201~205 (2000)
- Davidson JM, "Effects of androgen on sexual behavior in hypogonadal men", J Clin Endocrinol Metab, 48, pp.955~958 (1979)
- Skakkebaek NE, "Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double blind controlled study", Clin Endocrinol, 14, pp.49~61 (1981)
- Matsumoto AM, "Hormonal therapy of male hypogonadism", Endocrinol Metab Clin North Am, 23, pp.857~875 (1994)
- Practice Committee of the American Society for Reproductive Medicine, "Treatment of androgen deficiency in the aging male", Fertil Steril, 82(1), pp.S46~S50 (2004)
- Wu FC, "Hormonal approaches to male contraception: approaching reality", Mol Cell Endocrinol, 250, pp.2~7 (2006)
- Gui YL, "Male hormonal contraception: suppression of spermatogenesis by injectable testosterone undecanoate alone or with levonorgestrel implants in chinese men", J Androl, 25, pp.720~727 (2004)